Zobrazeno 1 - 10
of 507
pro vyhledávání: '"Manuel Nava"'
Autor:
Edgardo Mengual-Moreno, Manuel Nava, Alexander Manzano, Daniela Ariza, Luis D’Marco, Ana Castro, María A. Marquina, Marlon Hernández, Carlos Corredor-Pereira, Ana Checa-Ros, Valmore Bermúdez
Publikováno v:
Biomedicines, Vol 12, Iss 2, p 283 (2024)
The novel disease produced by SARS-CoV-2 mainly harms the respiratory tract, but it has shown the capacity to affect multiple organs. Epidemiologic evidence supports the relationship between Coronavirus Disease 2019 (COVID-19) and pancreatic and hepa
Externí odkaz:
https://doaj.org/article/6fb9a39a32d1443b9edd9dd58308a813
Autor:
Sergia Linares, Valmore Bermúdez, Juan Salazar, Manuel Nava, Ángel Ortega, Luis Olivar, María Calvo, María Sofía Martínez, Alex Morales-Carrasco, Maricarmen Chacín, Joselyn Rojas
Publikováno v:
Revista Peruana de Medicina Experimental y Salud Pública, Vol 37, Iss 3, Pp 412-22 (2020)
Objective: To carry out a clinical-epidemiological analysis of high-density lipoprotein cholesterol subfractions (HDL-C) in adults from Maracaibo, Venezuela. Materials and methods: A descriptive and cross-sectional study of the database from the Metb
Externí odkaz:
https://doaj.org/article/2ca816a929b34895a4f6513373275761
Autor:
Luis D’Marco, Ana Checa-Ros, Dionilux Gamero, Carlos Soto, Juan Salazar, Manuel Nava, Valmore Bermúdez, Fabiola Dapena
Publikováno v:
Healthcare, Vol 11, Iss 1, p 72 (2022)
Introduction: secondary hyperparathyroidism (SHP) is frequent in patients with chronic kidney disease (CKD), particularly in those in dialysis. To treat this complication, the current options available include phosphorus restriction, phosphate binder
Externí odkaz:
https://doaj.org/article/f1ce2b9190634f7f8f79c539b5e2c77d
Autor:
Valmore Bermúdez, Pablo Durán, Edward Rojas, María P. Díaz, José Rivas, Manuel Nava, Maricarmen Chacín, Mayela Cabrera de Bravo, Rubén Carrasquero, Clímaco Cano Ponce, José Luis Górriz, Luis D´Marco
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Adipose tissue (AT) biology is linked to cardiovascular health since obesity is associated with cardiovascular disease (CVD) and positively correlated with excessive visceral fat accumulation. AT signaling to myocardial cells through soluble factors
Externí odkaz:
https://doaj.org/article/064ee066936d45889c7bcfb78504dcbc
Autor:
Luis D'Marco, Valery Morillo, José Luis Gorriz, María K. Suarez, Manuel Nava, Ángel Ortega, Heliana Parra, Nelson Villasmil, Joselyn Rojas-Quintero, Valmore Bermúdez
Publikováno v:
Journal of Diabetes Research, Vol 2021 (2021)
Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) has increased substantially in medical practice due to their documented benefits in cardiorenal
Externí odkaz:
https://doaj.org/article/2429d38f9c04442fa80e1693aa5bb47e
Autor:
Valmore Bermúdez, Juan Salazar, Jorge Fuenmayor, Manuel Nava, Ángel Ortega, Pablo Duran, Milagros Rojas, Roberto Añez, Alejandra Rivas-Montenegro, Lissé Angarita, Maricarmen Chacín, Clímaco Cano, Manuel Velasco, Joselyn Rojas
Publikováno v:
Journal of Obesity, Vol 2021 (2021)
Background. Visceral adiposity is related to insulin resistance (IR), a metabolic state considered as a risk factor for other cardiometabolic diseases. In that matter, mathematical indexes such as the visceral adiposity index (VAI) and the lipid accu
Externí odkaz:
https://doaj.org/article/47dcc8884cc54adc94a384bcd38119ea
Autor:
Ángel Ortega, Juan Salazar, Néstor Galban, Milagros Rojas, Daniela Ariza, Mervin Chávez-Castillo, Manuel Nava, Manuel E. Riaño-Garzón, Edgar Alexis Díaz-Camargo, Oscar Medina-Ortiz, Valmore Bermúdez
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 8, p 4196 (2022)
The placebo effect can be defined as the improvement of symptoms in a patient after the administration of an innocuous substance in a context that induces expectations regarding its effects. During recent years, it has been discovered that the placeb
Externí odkaz:
https://doaj.org/article/8981a7d9ce2049dc88fda7ce679b7683
Autor:
Juan Salazar, Daniela Pirela, Manuel Nava, Ana Castro, Lissé Angarita, Heliana Parra, Samuel Durán-Agüero, Diana Marcela Rojas-Gómez, Néstor Galbán, Roberto Añez, Maricarmen Chacín, Andrea Diaz, Nelson Villasmil, Juan Bautista De Sanctis, Valmore Bermúdez
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 6, p 3133 (2022)
Cardiovascular disease (CVD) is a global public health issue due to its high morbidity, mortality, and economic impact. The implementation of innovative therapeutic alternatives for CVD is urgently required. Specialized proresolving lipid mediators (
Externí odkaz:
https://doaj.org/article/dde8099c5e434cc78d600adf4b89c9a6
Autor:
María Sofía Martínez, Alexander Manzano, Luis Carlos Olivar, Manuel Nava, Juan Salazar, Luis D’Marco, Rina Ortiz, Maricarmen Chacín, Marion Guerrero-Wyss, Mayela Cabrera de Bravo, Clímaco Cano, Valmore Bermúdez, Lisse Angarita
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 17, p 9504 (2021)
Type 2 Diabetes Mellitus (T2DM) is one of the most prevalent chronic metabolic disorders, and insulin has been placed at the epicentre of its pathophysiological basis. However, the involvement of impaired alpha (α) cell function has been recognized
Externí odkaz:
https://doaj.org/article/ef80860dca1048c281a3a7b27e093337
Autor:
Milagros Rojas, Mervin Chávez-Castillo, Daniela Pirela, Heliana Parra, Manuel Nava, Maricarmen Chacín, Lissé Angarita, Roberto Añez, Juan Salazar, Rina Ortiz, Samuel Durán Agüero, Marbel Gravini-Donado, Valmore Bermúdez, Edgar Díaz-Camargo
Publikováno v:
Nutrients, Vol 13, Iss 7, p 2254 (2021)
Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central obesity, hyperglycemia, hypertension, and dyslipidemias. The syndrome affects 25% of adults worldwide. The definition of MS has evolved over the last 80 years, wi
Externí odkaz:
https://doaj.org/article/c1ae04ce424c4072adf83a2e5553b603